【Good News】Deep Harbour Cell Valley Awarded the Title of "Key Innovative Enterprise Introduced by Shenzhen"!

Recently, the Shenzhen Science and Technology Innovation Bureau officially issued a notice, granting Deep Harbour Cell Valley Healthcare and Technology Co.Ltd the title of "Key Innovative Enterprise Introduced by Shenzhen." This recognition signifies that the company's innovative capabilities and development potential in the field of medical technology have been acknowledged. A total of 16 enterprises were included in this round of qualifications, with Deep Harbour Cell Valley successfully selected for its pioneering exploration in the field of cell therapy.

This qualification is based on the relevant provisions of the "Several Measures of the Shenzhen Science and Technology Innovation Commission on Strengthening the 'Double Recruitment and Double Introduction' of Science and Technology to Support High-Quality Development." After a rigorous uation process, the approved enterprises can apply for various science and technology programs in Shenzhen targeted at high-tech enterprises, and enjoy special support policies such as conditional acceptance for research conditions and "project first, funding later." This will further accelerate Deep Harbour Cell Valley's progress in core technology breakthroughs, achievement transformation, and industrial implementation.

Leveraging its domestically leading industrial-grade retroviral vector technology (PackRV-SS system), Deep Harbour Cell Valley has established a one-stop service platform covering the entire chain of cell therapy, spanning areas such as new drug R&D, clinical translation, cell preparation, and healthcare applications. In the future, Deep Harbour Cell Valley will seize this opportunity to fully utilize the advantages of Shenzhen's science and technology innovation policies, continuously increase R&D and innovation investments, deepen clinical application research in cell therapy technology, promote the deep integration of industry, academia, and research, and contribute to the high-quality development of the life and health industry in the Guangdong-Hong Kong-Macao Greater Bay Area.